Brief: Avalo Therapeutics Gets Notice From Nasdaq on Listing Extention and Compliance Exceptions

Avalo Therapeutics

16/11/2023 12:26

Nov 16 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO THERAPEUTICS: ON NOV 14, GOT NOTICE FROM NASDAQ,
PANEL
GRANTED CO EXCEPTION FROM COMPLIANCE WITH MVLS RULE, BID PRICE
RULE
    * AVALO THERAPEUTICS INC- PURSUANT TO NOTICE FROM NASDAQ,
PANEL
GRANTED CO EXTENSION OF CONTINUED LISTING UNTIL DECEMBER 29,
2023

Further company coverage:  AVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))